NCT01500057View on ClinicalTrials.gov

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 10, 2016

Study Completion Date

October 10, 2016

Conditions
Benign Prostatic Hyperplasia (BPH)
Interventions
DEVICE

Greenlight XPS Laser

Treatment of BPH with Greenlight XPS laser

DEVICE

BiVAP Saline Vaporization of the prostate

treatment of BPH with BiVAP Saline Vaporization

Trial Locations (1)

11215

Brooklyn Urology Research Group, Brooklyn

Sponsors

Collaborators (1)

American Medical Systems
All Listed Sponsors
collaborator

American Medical Systems

INDUSTRY

collaborator

Richard Wolf Medical Instruments Corporation (RWMIC)

UNKNOWN

lead

Brooklyn Urology Research Group

OTHER

NCT01500057 - Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter